What existed before Wellbeing International Foundation? It sounds like a simple question. It isn't. Wellbeing today presents itself as an international organisation built around Cell-Free Therapy, with a German laboratory, a network of partner clinics, a central management team and a scientific history it says stretches back decades. Its current website describes a research heritage extending well before the modern organisation and says many of the people involved in the earl

Behind Wellbeing — Chapter Three n Chapter Two, we stopped counting clinics and started following the treatment. That changed the picture. Wellbeing International Foundation's 23-clinic network appears not to operate like a conventional chain of hospitals or medical centres owned by one organisation. Instead, the evidence points towards a distributed system involving approved collection points, independent clinicians, a German laboratory and clinical locations capable of admi

Behind Wellbeing — Chapter Two Wellbeing International Foundation presents an impressive international footprint. Its current website says Cell-Free Therapy is processed at a single GMP-certified laboratory in Germany and delivered through a network of 23 partner clinics. It lists locations across the United States, Europe, the Middle East, Africa and the Pacific. Wellbeing International Foundation Look at that description quickly and it is easy to picture a conventional inte

Behind Wellbeing — Chapter One Wellbeing International Foundation presents Cell-Free Therapy internationally, describes more than twenty years of research and says it works through a network spanning multiple continents. But what actually constitutes Wellbeing International Foundation as a physical organisation? Where are its clinics? Where are its scientists? Where is its laboratory? And when a patient says they have been “treated by Wellbeing,” who actually treated them? Fo

The Men Behind Wellbeing — Chapter Twelve Chapter Eleven asked what an investor is actually buying. Now we follow the money. Wellbeing International Foundation says it is raising private capital to support research, international clinical relationships and operational expansion. But before an investor transfers a single pound, dollar or euro, there is a more basic question: which legal entity receives the money, what happens to it after it arrives, and what enforceable claim

The Men Behind Wellbeing — Chapter Eleven Wellbeing International Foundation is raising private capital to fund research and expansion. But after ten chapters following the people, science, patents and corporate history behind the organisation, a more urgent question emerges. Before anyone invests, can they establish exactly what they are buying, which entity owns the assets, what protects the technology, and what happens to their money if the scientific or commercial proposi

The Men Behind Wellbeing — Chapter Ten We have established that Stephen Ray's microvesicle technology entered the patent system through Lydac Neuroscience. We have also established that Wellbeing now promotes an autologous Cell-Free Therapy built around extracellular vesicles. The question is no longer whether the two stories look similar. It is whether the documentary record can show how—or whether—they are legally connected. Chapter Nine ended with a challenge: Show the cha

The Men Behind Wellbeing — Chapter Nine We followed Stephen Ray’s science backwards through patents, Lydac Neuroscience and ultimately the company’s insolvency. Now the investigation returns to where it began: Wellbeing International Foundation. If the Cell-Free Therapy being promoted today developed from the same scientific lineage as the microvesicle technology once assigned to Lydac, where did Wellbeing obtain the rights—and what does it actually own? For the last several

The Men Behind Wellbeing — Chapter Eight Lydac Neuroscience was the company historically associated with Stephen Ray’s microvesicle intellectual property. Andrew Chancellor later became its director. In December 2018, the company entered administration. To understand what happened to the science, we first need to understand what happened to the company—and, crucially, its assets. Chapter Seven established the chronology. Stephen Ray was involved with Lydac Neuroscience from i

The Men Behind Wellbeing — Chapter Nine Lydac Neuroscience once held patent rights over Stephen Ray's microvesicle technology. Lydac subsequently entered insolvency and has now been dissolved. Today, Wellbeing International Foundation promotes a Cell-Free Therapy built around extracellular vesicles and is raising investment to support its research and expansion. If these technologies share the same scientific lineage, one question becomes unavoidable: where did the intellectu

The Men Behind Wellbeing — Chapter Eight Lydac Neuroscience held intellectual property associated with Stephen Ray's microvesicle research. Andrew Chancellor later became a director. Then, in December 2018, the biotechnology company entered administration. This time, we move beyond the patent records and into the insolvency file itself. At the end of Chapter Seven, I said there was one set of documents I wanted to see next. The insolvency records. Not another interview. Not a

The Men Behind Wellbeing — Chapter Seven We followed Stephen Ray's microvesicle patents and found Lydac Neuroscience Limited. Now Companies House records reveal something considerably more important: both Stephen Ray and Andrew Chancellor served as directors of the company. Years later, Lydac entered administration and liquidation. So what happened—and what became of its intellectual property? Sometimes an investigation reaches a point where separate pieces of evidence sudden

The Men Behind Wellbeing — Chapter Six The patent trail has taken this investigation beyond Wellbeing International Foundation and Natural Biosciences. Official records identify another company associated with Stephen Ray’s microvesicle intellectual property: Lydac Neuroscience Limited. Who was behind it, what did it control, and what happened to the technology afterwards? Investigations change when documents replace assumptions. In the previous chapter, we established someth

The Men Behind Wellbeing — Chapter Five Wellbeing International Foundation credits Stephen Ray with decades of research behind its Cell-Free Therapy. Patent records provide something more concrete: a documented intellectual-property trail involving microvesicles that reaches back to 2008. But what do those patents actually establish—and what do they not prove? In the previous chapter, we reached an important point in the investigation. Andrew Chancellor has publicly described

The Men Behind Wellbeing — Chapter Four Andrew Chancellor came from banking and international recruitment. Stephen Ray came from scientific research. Their partnership appears to mark the point at which years of biological research began its journey towards becoming the commercial Cell-Free Therapy operation promoted by Wellbeing International Foundation today. There are two very different skills required to turn scientific research into a commercial medical product. Someone

Following Andrew Chancellor’s Corporate Trail Before regenerative medicine came banking and recruitment. What does the documentary record tell us about the businessman who became Wellbeing’s CEO? The previous two chapters raised an important question. How did Andrew Chancellor move from banking and international recruitment to becoming Chief Executive Officer of an organisation delivering regenerative biologics? Wellbeing International Foundation’s own biography describes a c

The Gatekeeper Who decides whether a patient qualifies for Cell-Free Therapy? There is a point at which a biotechnology business stops being an abstract discussion about science. A patient picks up the telephone. They may be frightened. They may have exhausted conventional options. They may be living with a serious illness or degenerative condition. They want to know one thing: Can you help me? For Wellbeing International Foundation, answering that question is particularly im

From Banking to Biologics How a career in finance and recruitment led to the leadership of a regenerative-medicine organisation Throughout this investigation, I have repeatedly returned to one principle. Before examining what an organisation claims, understand the people making those claims. That principle led me first to Wellbeing International Foundation's Chairman, Max Lewinsohn. Now it leads to the organisation's Chief Executive Officer. Andrew Chancellor. If you encounte

Following the Patient Money Behind Cell-Free Therapy There is a moment in every investigation when separate pieces of information suddenly begin to connect. For this investigation, that moment came when I returned to something I had discovered much earlier. The price. During my earlier investigation into Wellbeing International Foundation, a prospective patient enquiry resulted in a proposed Cell-Free Therapy programme carrying a price of approximately £37,000. In a separate

What Exactly Are Investors Being Asked to Believe? At some point, almost every emerging biotechnology company faces the same challenge. Science costs money. Research costs money. Laboratories cost money. Clinical expansion costs money. And eventually, someone has to finance it. That is where investors enter the story. Throughout this investigation, I have examined Wellbeing International Foundation from several different perspectives. First as a healthcare organisation. Then